Cetera Investment Advisers Mannkind Corp Transaction History
Cetera Investment Advisers
- $42.2 Billion
- Q2 2024
A detailed history of Cetera Investment Advisers transactions in Mannkind Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 22,705 shares of MNKD stock, worth $168,925. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,705
Previous 21,232
6.94%
Holding current value
$168,925
Previous $96,000
22.92%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MNKD
# of Institutions
228Shares Held
133MCall Options Held
1.43MPut Options Held
849K-
Black Rock Inc. New York, NY22.6MShares$168 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$115 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY10.1MShares$75 Million5.97% of portfolio
-
State Street Corp Boston, MA9.56MShares$71.1 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.76MShares$65.2 Million0.62% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.91B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...